Jianxiang Chi

Nicandrou Papamina Avenue
Nicosia, 2032, Cyprus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe glioma.

Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe glioma.

Journal: Frontiers in oncology

Published: December 08, 2025

Population genetic variation characterised through serial independent pool-seq: the Cyprus Genome Project.

Population genetic variation characterised through serial independent pool-seq: the Cyprus Genome Project.

Journal: Scientific reports

Published: October 31, 2025

CD2 costimulation strength: A key regulator of T cell function and anti-tumor immunity that is epigenetically regulated.

CD2 costimulation strength: A key regulator of T cell function and anti-tumor immunity that is epigenetically regulated.

Journal: iScience

Published: April 25, 2025

Dysbiosis in the Gut Microbiome of Pembrolizumab-Treated Non-Small Lung Cancer Patients Compared to Healthy Controls Characterized Through Opportunistic Sampling.

Dysbiosis in the Gut Microbiome of Pembrolizumab-Treated Non-Small Lung Cancer Patients Compared to Healthy Controls Characterized Through Opportunistic Sampling.

Journal: Thoracic cancer

Published: November 22, 2024

Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy.

Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy.

Journal: Biology direct

Published: October 15, 2023

Fecal Microbiota and Associated Volatile Organic Compounds Distinguishing No-Adenoma from High-Risk Colon Adenoma Adults.

Fecal Microbiota and Associated Volatile Organic Compounds Distinguishing No-Adenoma from High-Risk Colon Adenoma Adults.

Journal: Metabolites

Published: May 22, 2023

A de novo SFMBT1 pathogenic variant identified in a boy with Poland syndrome.

A de novo SFMBT1 pathogenic variant identified in a boy with Poland syndrome.

Journal: Cold Spring Harbor molecular case studies

Published: November 25, 2021

Clinical values of gene alterations as marker of minimal residual disease in non-M3 acute myeloid leukemia.

Clinical values of gene alterations as marker of minimal residual disease in non-M3 acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 22, 2021

Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors.

Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors.

Journal: Frontiers in oncology

Published: October 07, 2021

Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway.

Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway.

Journal: Frontiers in cell and developmental biology

Published: March 26, 2021

HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia.

HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia.

Journal: Cell death & disease

Published: January 31, 2020

MicroRNA‑143 increases cell apoptosis in myelodysplastic syndrome through the Fas/FasL pathway both in vitro and in vivo.

MicroRNA‑143 increases cell apoptosis in myelodysplastic syndrome through the Fas/FasL pathway both in vitro and in vivo.

Journal: International journal of oncology

Published: March 07, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026